Ethnicity/Race and Age-Specific Variations of Serum AMH in Women-A Review

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2021 Feb 26

PMID 33633682

Citations 23

Authors

Alexander M Kotlyar

David B Seifer

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: In this review, we summarize ethnic/race- and age-related variation in AMH and discuss the underpinnings behind these differences.

Recent Findings: Anti-mullerian hormone (AMH) has become a widely used method of ovarian reserve testing over the last 15 years. Numerous studies have shown substantial ethnic/race and age-related differences. When compared to age-matched Caucasian women, AMH levels tend to be lower in black and Hispanic women. Chinese women tend to have significantly greater AMH levels prior to age 25 than Caucasian women. When considering subpopulations within ethnicities, at least one study noted lower AMH levels among Maya women compared to other Hispanic women. Age exhibits a positive trend with AMH up until at least 25 years of age with a consistent decline after 34 years of age extending to menopause.

Summary: AMH levels are highly variable among ethnicities and race with higher age-matched levels typically seen in Caucasian women. Age does not exhibit a consistent linear relationship with AMH, but a consistent decline is seen starting in the third decade of life and proceeding to menopause.

Citing Articles

Critical factors influencing live birth rates in fresh embryo transfer for IVF: insights from cluster ensemble algorithms.

Yu Z, Zheng X, Sun J, Zhang P, Zhong Y, Lv X Sci Rep. 2025; 15(1):3734.

PMID: 39881210 PMC: 11779932. DOI: 10.1038/s41598-025-88210-1.

Distribution and Related Influencing Factors of AMH Level in Family-Planning Women of Childbearing Age: A Cross-Sectional Study from Beijing, China.

Song J, Gao S, Zhao L, Tong X Int J Womens Health. 2025; 17:99-107.

PMID: 39866819 PMC: 11766139. DOI: 10.2147/IJWH.S499220.

Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity.

Baba T Reprod Med Biol. 2025; 24(1):e12630.

PMID: 39845478 PMC: 11751892. DOI: 10.1002/rmb2.12630.

The Relationship Between Body Composition Parameters and the Intake of Selected Nutrients, and Serum Anti-Müllerian Hormone (AMH) Levels in the Context of Ovulatory Infertility.

Skowronska M, Pawlowski M, Buczynska A, Wiatr A, Dyszkiewicz A, Wenta A Nutrients. 2024; 16(23).

PMID: 39683543 PMC: 11644442. DOI: 10.3390/nu16234149.

Functional ovarian reserve in women with Sickle Cell disease: A systematic review.

Silva C, Passos N, Ribeiro A, Mattos R, Torquato E, Mirada E JBRA Assist Reprod. 2024; 28(4):683-690.

PMID: 39626006 PMC: 11622400. DOI: 10.5935/1518-0557.20240067.

References

de Koning C, McDonnell J, Themmen A, de Jong F, Homburg R, Lambalk C . The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls. Hum Reprod. 2008; 23(6):1416-23. DOI: 10.1093/humrep/den092. View

Seifer D, MacLaughlin D, Christian B, Feng B, Shelden R . Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002; 77(3):468-71. DOI: 10.1016/s0015-0282(01)03201-0. View

Khan H, Bhatti S, Suhail S, Gul R, Awais A, Hamayun H . Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40.... Reprod Biol Endocrinol. 2019; 17(1):20. PMC: 6371573. DOI: 10.1186/s12958-019-0464-0. View

Reichman D, Goldschlag D, Rosenwaks Z . Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome. Fertil Steril. 2014; 101(4):1012-8.e1. DOI: 10.1016/j.fertnstert.2013.12.039. View

Weenen C, Laven J, von Bergh A, Cranfield M, Groome N, Visser J . Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004; 10(2):77-83. DOI: 10.1093/molehr/gah015. View

Merhi Z, Seifer D, Weedon J, Adeyemi O, Holman S, Anastos K . Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study. Fertil Steril. 2012; 98(1):228-34. PMC: 3389125. DOI: 10.1016/j.fertnstert.2012.03.029. View

Iglesias C, Banker M, Mahajan N, Herrero L, Meseguer M, Garcia-Velasco J . Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women. Fertil Steril. 2014; 102(1):244-9. DOI: 10.1016/j.fertnstert.2014.03.050. View

Armstrong A, Plowden T . Ethnicity and assisted reproductive technologies. Clin Pract (Lond). 2013; 9(6):651-658. PMC: 3595611. DOI: 10.2217/cpr.12.65. View

Freeman E, Gracia C, Sammel M, Lin H, Lim L, Strauss 3rd J . Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril. 2006; 87(1):101-6. DOI: 10.1016/j.fertnstert.2006.05.074. View

10.

Tal R, Seifer D . Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve. Int J Endocrinol. 2013; 2013:818912. PMC: 3857838. DOI: 10.1155/2013/818912. View

11.

Seifer D, Simsek B, Wantman E, Kotlyar A . Status of racial disparities between black and white women undergoing assisted reproductive technology in the US. Reprod Biol Endocrinol. 2020; 18(1):113. PMC: 7677830. DOI: 10.1186/s12958-020-00662-4. View

12.

Sowers M, McConnell D, Yosef M, Jannausch M, Harlow S, Randolph Jr J . Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann N Y Acad Sci. 2010; 1204:95-103. PMC: 3296522. DOI: 10.1111/j.1749-6632.2010.05523.x. View

13.

Lee M, Donahoe P . Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev. 1993; 14(2):152-64. DOI: 10.1210/edrv-14-2-152. View

14.

La Marca A, Sighinolfi G, Giulini S, Traglia M, Argento C, Sala C . Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles. Reprod Biomed Online. 2010; 21(4):463-9. DOI: 10.1016/j.rbmo.2010.05.009. View

15.

Tal R, Seifer D . Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017; 217(2):129-140. DOI: 10.1016/j.ajog.2017.02.027. View

16.

Marsh E, Bernardi L, Steinberg M, Chavez P, Visser J, Carnethon M . Novel correlates between antimüllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old). Fertil Steril. 2016; 106(2):443-450.e2. PMC: 4975664. DOI: 10.1016/j.fertnstert.2016.04.008. View

17.

Jung S, Allen N, Arslan A, Baglietto L, Brinton L, Egleston B . Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women. Fertil Steril. 2017; 107(4):1012-1022.e2. PMC: 5426228. DOI: 10.1016/j.fertnstert.2017.02.105. View

18.

Bernardi L, Carnethon M, Chavez P, Ikhena D, Neff L, Baird D . Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women. Obesity (Silver Spring). 2016; 25(1):229-235. PMC: 5182136. DOI: 10.1002/oby.21681. View

19.

Dewailly D, Andersen C, Balen A, Broekmans F, Dilaver N, Fanchin R . The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014; 20(3):370-85. DOI: 10.1093/humupd/dmt062. View

20.

Fleming R, Seifer D, Frattarelli J, Ruman J . Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reprod Biomed Online. 2015; 31(4):486-96. DOI: 10.1016/j.rbmo.2015.06.015. View